144 related articles for article (PubMed ID: 38563804)
1. Exploring the Impact of Different Inflammatory Cytokines on Hepatitis C Virus Infection.
Bader El Din NG; Farouk S
J Interferon Cytokine Res; 2024 Jun; 44(6):233-243. PubMed ID: 38563804
[TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor 7 (TLR-7) and TLR-9 Agonists Improve Hepatitis C Virus Replication and Infectivity Inhibition by Plasmacytoid Dendritic Cells.
Dominguez-Molina B; Machmach K; Perales C; Tarancon-Diez L; Gallego I; Sheldon JL; Leal M; Domingo E; Ruiz-Mateos E
J Virol; 2018 Dec; 92(23):. PubMed ID: 30232187
[TBL] [Abstract][Full Text] [Related]
3. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
[TBL] [Abstract][Full Text] [Related]
4. HCV J6/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines.
Fang Z; Zhu K; Guo N; Zhang N; Guan M; Yang C; Pan Q; Wei R; Yang C; Deng C; Liu X; Zhao P; Leng Q
Pharm Res; 2015 Mar; 32(3):741-8. PubMed ID: 23619596
[TBL] [Abstract][Full Text] [Related]
5. IL-26 inhibits hepatitis C virus replication in hepatocytes.
Beaumont É; Larochette V; Preisser L; Miot C; Pignon P; Blanchard S; Hansen BT; Dauvé J; Poli C; Poranen MM; Lamourette P; Plaisance M; Morel A; Fickenscher H; Jeannin P; Roingeard P; Delneste Y
J Hepatol; 2022 Apr; 76(4):822-831. PubMed ID: 34952035
[TBL] [Abstract][Full Text] [Related]
6. HBV Bypasses the Innate Immune Response and Does Not Protect HCV From Antiviral Activity of Interferon.
Mutz P; Metz P; Lempp FA; Bender S; Qu B; Schöneweis K; Seitz S; Tu T; Restuccia A; Frankish J; Dächert C; Schusser B; Koschny R; Polychronidis G; Schemmer P; Hoffmann K; Baumert TF; Binder M; Urban S; Bartenschlager R
Gastroenterology; 2018 May; 154(6):1791-1804.e22. PubMed ID: 29410097
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C: From inflammatory pathogenesis to anti-inflammatory/hepatoprotective therapy.
Li H; Huang MH; Jiang JD; Peng ZG
World J Gastroenterol; 2018 Dec; 24(47):5297-5311. PubMed ID: 30598575
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection induces inflammatory cytokines and chemokines mediated by the cross talk between hepatocytes and stellate cells.
Nishitsuji H; Funami K; Shimizu Y; Ujino S; Sugiyama K; Seya T; Takaku H; Shimotohno K
J Virol; 2013 Jul; 87(14):8169-78. PubMed ID: 23678168
[TBL] [Abstract][Full Text] [Related]
9. Transmitted/founder hepatitis C viruses induce cell-type- and genotype-specific differences in innate signaling within the liver.
Mitchell AM; Stone AE; Cheng L; Ballinger K; Edwards MG; Stoddard M; Li H; Golden-Mason L; Shaw GM; Khetani S; Rosen HR
mBio; 2015 Feb; 6(2):e02510. PubMed ID: 25714713
[TBL] [Abstract][Full Text] [Related]
10. [Immunology of HCV infection: the causes of impaired cellular immune response and the effect of antiviral treatment].
Pár G; Berki T; Pálinkás L; Balogh P; Szereday L; Halász M; Szekeres-Barthó J; Miseta A; Hegedus G; Mózsik G; Hunyady B; Pár A
Orv Hetil; 2006 Apr; 147(13):591-600. PubMed ID: 16623441
[TBL] [Abstract][Full Text] [Related]
11. [Effect of interferon inductors on infection induced by hepatitis C virus and activity of mRNA cytokines in cell cultures SW-13 and MT-4].
Narovlianskiĭ AN; Deriabin PG; Vershinina MIu; Mezentseva MV; Ershov FI
Vopr Virusol; 2002; 47(6):17-21. PubMed ID: 12508677
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of Th1 hepatitis C virus (HCV)-specific responses in individuals with acute HCV who achieve sustained virological clearance after treatment.
Flynn JK; Dore GJ; Hellard M; Yeung B; Rawlinson WD; White PA; Kaldor JM; Lloyd AR; Ffrench RA;
J Gastroenterol Hepatol; 2013 Nov; 28(11):1770-81. PubMed ID: 23663030
[TBL] [Abstract][Full Text] [Related]
13. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
14. [Cytokine mediators in acute inflammation and chronic course of viral hepatitis].
Missale G; Ferrari C; Fiaccadori F
Ann Ital Med Int; 1995; 10(1):14-8. PubMed ID: 7727201
[TBL] [Abstract][Full Text] [Related]
15. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus Infection of Human Thyrocytes: Metabolic, Hormonal, and Immunological Implications.
Hammerstad SS; Blackard JT; Lombardi A; Owen RP; Concepcion E; Yi Z; Zhang W; Tomer Y
J Clin Endocrinol Metab; 2020 Apr; 105(4):1157-68. PubMed ID: 31784757
[TBL] [Abstract][Full Text] [Related]
17. Galectin-9 and Interferon-Gamma Are Released by Natural Killer Cells upon Activation with Interferon-Alpha and Orchestrate the Suppression of Hepatitis C Virus Infection.
Carreca AP; Gaetani M; Busà R; Francipane MG; Gulotta MR; Perricone U; Iannolo G; Russelli G; Carcione C; Conaldi PG; Badami E
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891518
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory status in human hepatic cirrhosis.
Martínez-Esparza M; Tristán-Manzano M; Ruiz-Alcaraz AJ; García-Peñarrubia P
World J Gastroenterol; 2015 Nov; 21(41):11522-41. PubMed ID: 26556984
[TBL] [Abstract][Full Text] [Related]
19. Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on Toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates.
Li K; Li NL; Wei D; Pfeffer SR; Fan M; Pfeffer LM
Hepatology; 2012 Mar; 55(3):666-75. PubMed ID: 22030901
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis.
Pollmann J; Götz JJ; Rupp D; Strauss O; Granzin M; Grünvogel O; Mutz P; Kramer C; Lasitschka F; Lohmann V; Björkström NK; Thimme R; Bartenschlager R; Cerwenka A
J Hepatol; 2018 Mar; 68(3):421-430. PubMed ID: 29100993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
